Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
John R. Power(UC San Diego Health System), Joe‐Elie Salem(Inserm), Javid J. Moslehi(University of California, San Francisco), Shi Huang(Vanderbilt University Medical Center), Anita Deswal(Michael E. DeBakey VA Medical Center), Nicolas L. Palaskas(The University of Texas MD Anderson Cancer Center), Lauren Gilstrap(Massachusetts General Hospital), Dimitri Arangalage, Stéphane Éderhy, Jennifer Cautela, Lorenz Lehman(Heidelberg University), Salim S. Hayek(Emory University), Franck Thuny, Aarti Asnani, Yuichi Tamura(Mita Hospital), Steven M. Ewer(UW Health University Hospital), Joachim Alexandre(Government of the United States of America), Arrush Choudhary(Beth Israel Deaconess Medical Center), Daniel Finke(Heidelberg University), Mandar A. Aras(University of California San Francisco Medical Center), Benay Özbay(University of Pittsburgh)
Cited by 14
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k